NEW YORK (TheStreet) -- CHANGE IN RATINGS
Bank of America
upgraded at Standpoint. BAC was upgraded from Hold to Accumulate. Stock looks attractively valued following the recent pullback, trading at just 1.15 tangible book value.
upgraded at UBS from Neutral to Buy. $150 price target. Estimates also boosted, given higher industry growth rates.
downgraded at Goldman from Buy to Neutral. Valuation call, based on a $48 price target.
rated new Outperform at Credit Suisse. ITRI was initiated with an Outperform rating, Credit Suisse said. $70 price target. Company operates in multiple growth areas.
upgraded at Goldman. LOW was upgraded from Neutral to Buy, Goldman Sachs said. $24 price target. Margins are finally starting to recover.
upgraded at Morgan Keegan. OTEX was upgraded from Market Perform to Outperform, Morgan Keegan said. $53 price target. Potential for margin expansion and new tax structure should help the company. Estimates also boosted.
upgraded at FBR from Market Perform to Outperform, FBR Capital Markets said. $57 price target. Company is growing sales faster than its peers.
STOCK COMMENTS / EPS CHANGES
Cabot Oil & Gas
estimates increased at Keybanc. COG estimates were raised through 2011. Continue to see growth potential in the Marcellus shale, despite lower natural gas prices. Buy rating and $48 price target.
numbers upped at Credit Suisse. DNR estimates were boosted through 2012, Credit Suisse said. Company's production growth should accelerate in the coming quarters. Neutral rating and new $22 price target.
estimates, target raised at Citigroup. Shares of EXC now seen reaching $39, according to Citigroup. Estimates also increased, given a better regulatory outlook. Hold rating.
estimates lowered at Sterne Agee. FL estimates were cut through 2011, Sterne Agee said. Margins could decline from peak levels. Neutral rating.
numbers boosted at Credit Suisse. Shares of HRL now seen reaching $46. Estimates also upped, given the company's higher realized margins. Neutral rating.
target reduced at Goldman. Shares of KAR now seen reaching $15, according to Goldman Sachs. Estimates also cut, given lower expected auction volumes. Neutral rating.
estimates raised at Credit Suisse. LO estimates were increased through 2012. Buyback program should add to earnings. Neutral rating and $82 price target.
numbers increased at Citigroup. MCHP estimates were raised through 2011, Citigroup said. Business has fully recovered from the downturn. Buy rating and new $36 price target.
estimates, target raised at Goldman. Shares of MON now seen reaching $73. Estimates also increased, Company received approval for Roundup soybean product in Brazil. Buy rating.
estimates upped at BMO through 2012, BMO Capital Markets said. Company is seeing better sales and margins. Outperform rating and $85 price target.
numbers raised at Oppenheimer. Shares of NEE now seen reaching $58, according to Oppenheimer. Estimates also increased, given higher rates in Floria. Outperform rating.
numbers boosted at BofA/Merrill. Shares of NEE now seen reaching $60. Last week's rate settlement will add to earnings. Buy rating.
estimates upped, target cut at Goldman. SJM estimates were boosted through 2013, Goldman Sachs said. On the other hand, the target was lowered to $69, given the declining market multiple. Neutral rating.
United Natural Foods
target upped at FBR to $38. Company should deliver better near-term sales growth.
estimates increased at Kaufman through 2011, Kaufman Bros. said. Company received more attractive financing terms. Hold rating.
estimates upped, target cut at Citigroup. Shares of WSM now seen reaching $32, according to Citigroup. On the other hand, estimates were raised, to match the company's new guidance. Hold rating.
This article was written by a staff member of TheStreet.